Armonica
Company

Last deal

$2M

Amount

Grant

Stage

31.08.2022

Date

3

all rounds

$5.95M

Total amount

date founded

Financing round

General

About Company
Armonica is a medtech company that develops its own long-read DNA sequencing technology for precision medicine applications.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Armonica Technologies

founded date

01.01.2015

founders

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

Armonica Technologies, an early-stage medtech firm, focuses on creating a unique long-read DNA sequencing platform for precision medicine purposes. Inspired by Benjamin Franklin's invention, The Glass Armonica, the company's proprietary technology, licensed from STC.UNM, allows for the sequencing of a complete human genome in minutes. By eliminating the need for library preparation and addressing computational and bioinformatic challenges, Armonica's platform empowers life science researchers to enhance their efficiency and productivity in research and discovery endeavors.
Contacts
Similar Companies
1000
Amaryllis Nucleics

Amaryllis Nucleics

Amaryllis Nucleics is a Bay Area-based start-up company that specializes in proprietary RNA sequencing methods.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

San Francisco, CA, USA

total rounds

1
Halcyon Molecular

Halcyon Molecular

Halcyon Molecular is a company developing advanced DNA manipulation technology for sequencing human genomes.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

Redwood City, CA, USA
TwinStrand Biosciences

TwinStrand Biosciences

TwinStrand Biosciences develops and commercializes duplex sequencing technology for DNA sequencing.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Seattle, WA, USA

total rounds

5

total raised

$83.5M
Qitan Technology

Qitan Technology

Qitan Technology is a developer of a genome sequencing technology that uses nanopores.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Chengdu, Sichuan, China

total rounds

7

total raised

$196.93M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$5.95M

Money Raised

Their latest funding was raised on 31.08.2022. Their latest investor New Mexico Vintage Fund. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
01.06.2022
1
$100K
18.10.2021
4
$2M
National Human Genome Research Institute

National Human Genome Research Institute

The National Human Genome Research Institute (NHGRI) is leading genomics research at the National Institutes of Health (NIH).

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bethesda, MD, USA

count Of Investments

13

count Of Exists

1
Co-Investors
Investors
6
1

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
New Mexico Vintage Fund

New Mexico Vintage Fund

New Mexico Vintage Fund invests in early-stage companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Venture Capital

Location

Santa Fe, NM, USA

count Of Investments

24
National Human Genome Research Institute

National Human Genome Research Institute

The National Human Genome Research Institute (NHGRI) is leading genomics research at the National Institutes of Health (NIH).

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bethesda, MD, USA

count Of Investments

13

count Of Exists

1
Tramway Venture Partners

Tramway Venture Partners

Albuquerque's Tramway Ventures invests in early-stage biotech, medtech, and health tech companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Albuquerque, NM, USA

count Of Investments

9

People

Founders
1
Steve Brueck
Steve Brueck

Steve Brueck

Steve is a Distinguished Professor of Electrical and Computer Engineering and of Physics, Emeritus at the University of New Mexico (UNM). Steve’s degrees are in Electrical Engineering (BS, Columbia University 1965, SM, MIT 1967 and PhD MIT 1971). Steve was a technical staff member at MIT Lincoln Laboratory from 1971 to 1985 when he joined UNM. He was appointed Director of the Center for High Technology Materials (CHTM) in 1987, stepping down as Director in 2013 and retiring from UNM as Distinguished Professor Emeritus in 2014. During his tenure, CHTM matured into an internationally respected research center in photonics, microelectronics and nanotechnology. Since its inception, CHTM has published over 2500 refereed journal articles, graduated over 460 MS and PhD students, been awarded over 207 US patents, and received over $208 M in research funding. He has been a member of the Board of Directors of LightPath Technologies, a global manufacturer, distributor and integrator of optical components and high-level assemblies since 2001. Steve has published over 450 refereed papers, has presented over 250 invited papers and seminars, and holds 73 US patents. He has been active in professional societies chairing the Conference on Lasers and Electro-Optics (CLEO) in 2000, and the Electron, Ion, Photon Beam Nanofabrication and Applications (EIPBN) conference in 2008, and the Lithography Workshop in 2013. He has served on a number of National Academy Panels and Boards. He is a fellow of the IEEE, the OSA, the AAAS, and the National Academy of Inventors. In 2010 he was the first UNM Science and Technology Corporation Innovation fellow. In 2013 he was the inaugural recipient of the UNM Presidential Medal of Distinction for his contributions to the University of New Mexico.

current job

Armonica
Armonica

organization founded

1

Steve Brueck

Employee Profiles
2
Victor Esch

Victor Esch

CEO

Steve Brueck

Steve Brueck

FOUNDER & CSO

Activity

Recent News
3
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month